弥漫性中线胶质瘤的侵袭和转移依赖细胞自主信号传导
研究利用患者来源的胶质瘤干细胞(GSC)构建患者特异性3D模型,发现其可再现亲本肿瘤的侵袭行为,证明DMG的浸润是肿瘤细胞的自主特征。研究区分了间充质样和阿米巴样两种迁移模式,并将阿米巴样模式与最具侵袭性的肿瘤来源GSC相关联,转录组学分析显示阿米巴样肿瘤具有少突胶质祖细胞样特征,其高收缩性细胞骨架和降低的黏附能力由骨形态发生蛋白7(BMP7)过表达驱动。BMP7下游的MEK、ERK和Rho/ROCK激酶被鉴定为可干预的靶点。
要点
- 患者来源GSC的3D模型可再现亲本肿瘤的侵袭行为,提示DMG浸润是肿瘤细胞自主特征。
- 阿米巴样迁移模式与最具侵袭性的肿瘤来源GSC相关,该类肿瘤呈少突胶质祖细胞样特征。
- BMP7过表达驱动高收缩性细胞骨架和降低的黏附能力,其下游MEK、ERK和Rho/ROCK激酶为可干预靶点。
核心结论
- 患者来源GSC可作为患者分层的预测工具,以调整放疗策略。
- 自分泌和短程BMP7相关信号成为可药物干预的靶点,以预防DMG扩散和转移。
研究设计与样本
- 研究利用患者来源的胶质瘤干细胞(GSC)构建患者特异性3D模型,以模拟个体间侵袭差异并阐明细胞支持机制。
- 研究采用器官体和原发肿瘤的转录组学分析。
主要发现
- GSC的3D模型可再现亲本肿瘤的侵袭行为,证明DMG的浸润是肿瘤细胞的自主特征。
- 研究区分了间充质样和阿米巴样两种迁移模式,并将阿米巴样模式与最具侵袭性肿瘤来源的GSC相关联。
- 转录组学显示阿米巴样肿瘤为少突胶质祖细胞样,具有高度收缩性细胞骨架和降低的黏附能力,由BMP7的关键过表达驱动。
- BMP7刺激下游激活的MEK、ERK和Rho/ROCK激酶被鉴定为控制肿瘤细胞运动的可干预靶点。
临床怎么用
- 作者认为患者来源GSC可作为患者分层的预测工具,以调整放疗策略。
- 作者认为自分泌和短程BMP7相关信号是可药物干预的靶点,以预防DMG扩散和转移。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Diffuse midline gliomas (DMG) are pediatric tumors with negligible 2-year survival after diagnosis characterized by their ability to infiltrate the central nervous system. In the hope of controlling the local growth and slowing the disease, all patients receive radiotherapy. However, distant progression occurs frequently in DMG patients. Current clues as to what causes tumor infiltration circle mainly around the tumor microenvironment, but there are currently no known determinants to predict the degree of invasiveness. METHODS: In this study, we use patient-derived glioma stem cells (GSCs) to create patient-specific 3D avatars to model interindividual invasion and elucidate the cellular supporting mechanisms. RESULTS: We show that GSC models in 3D mirror the invasive behavior of the parental tumors, thus proving the ability of DMG to infiltrate as an autonomous characteristic of tumor cells. Furthermore, we distinguished 2 modes of migration, mesenchymal and ameboid-like, and associated the ameboid-like modality with GSCs derived from the most invasive tumors. Using transcriptomics of both organoids and primary tumors, we further characterized the invasive ameboid-like tumors as oligodendrocyte progenitor-like, with highly contractile cytoskeleton and reduced adhesion ability driven by crucial over-expression of bone morphogenetic pathway 7 (BMP7). Finally, we deciphered MEK, ERK, and Rho/ROCK kinases activated downstream of the BMP7 stimulation as actionable targets controlling tumor cell motility. CONCLUSIONS: Our findings identify 2 new therapeutic avenues. First, patient-derived GSCs represent a predictive tool for patient stratification in order to adapt irradiation strategies. Second, autocrine and short-range BMP7-related signaling becomes a druggable target to prevent DMG spread and metastasis.
引用
- Bruschi M, Midjek L, Ajlil Y, et al. Diffuse midline glioma invasion and metastasis rely on cell-autonomous signaling. Neuro Oncol. 2024. PMID: 37702430. doi:10.1093/neuonc/noad161
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。